This study is in progress, not accepting new patients
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
Summary
- Eligibility
- for people ages 18-70 (full criteria)
- Location
- at UC Irvine UCSF
- Dates
- study startedstudy ends around
- Principal Investigator
- by Michelle Min (uci)Anna Haemel (ucsf)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientists at University of California Health
- Michelle Min (uci)
Associate Clinical Professor, Dermatology, School of Medicine. Authored (or co-authored) 24 research publications - Anna Haemel (ucsf)
Dr. Anna Haemel is a dermatologist who treats patients with all types of skin disease. Her expertise includes care for patients who have internal organ involvement and underlying systemic disease, such as rheumatologic conditions and inflammatory bowel disease. Haemel earned her medical degree at the Warren Alpert Medical School of Brown University.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- AstraZeneca
- ID
- NCT06015737
- Phase
- Phase 3 Lupus Research Study
- Study Type
- Interventional
- Participants
- About 339 people participating
- Last Updated